Customer Service: 800-778-7436     

To access your product click the Log In link at the top right of the screen. Once inside your account, you will be able to access your Packages, Self-Study Product, and Webinar Registrations.

Sign In to Your Surgent Account

Forgot Username or Password | Register for an Account

Reasonable Suspicion (REAS)

Monday, April 21, 2025
02:00 PM - 03:00 PM (Eastern)

Amy McAndrew, Esquire

  • Format Webinar
  • Credits 1.00
  • Level Basic
  • Field of Study Personnel/Human Resources (1)

$59.00


Overview

Given the opioid epidemic and the legalization of medical and recreational marijuana in a growing number of states, many employers are concerned about the impact drugs and alcohol may be having on the safety and security of their workplaces. Reasonable suspicion testing is among the best ways for employers to identify whether an employee is under the influence of drugs or alcohol while working. This webinar explores what managers and supervisors need to know to implement a Reasonable Suspicion Testing Policy.

Major Topics:

  • The psychosocial, physiological, and behavioral aspects of drug and alcohol abuse in the workplace
  • The impact of drug and alcohol abuse on workplace safety
  • The possible connection between performance issues and drug or alcohol abuse
  • The role of documentation in reasonable suspicion testing
  • Confidentiality concerns in the testing process

Learning Objectives

  • Recognize the signs and symptoms of drug and alcohol use, including withdrawal symptoms
  • Understand how to help enforce the company’s drug and alcohol abuse policy through reasonable suspicion testing
  • Explain the steps for observing, documenting, interviewing, and referring employees for testing based upon reasonable suspicion

Who should take this course:

Human resources professionals and managers

None

None

No

No

No

loading

Loading...

Loading...

Thank You!

YOU HAVE ADDED THE FOLLOWING TO YOUR CART:


Loading...

CPE Webinars
CPE Webinars

Thank You!

Thank You! Your subscription has been submitted.